Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma (Q33376304)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma |
scientific article |
Statements
1 reference
Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma (English)
1 reference
Pier Luigi Zinzani
1 reference
Michele Baccarani
1 reference
Enrica Marchi
1 reference
Stefano Pileri
1 reference
Monica Tani
1 reference
Vittorio Stefoni
1 reference
Mariapaola Fina
1 reference
Cinzia Pellegrini
1 reference
Lapo Alinari
1 reference
Antonio de Vivo
1 reference
Elena Sabattini
1 reference
20 August 2007
1 reference
1 reference
Identifiers
1 reference